Diabetes Risk Test

Our patented ““Beta-Cell Test” developed and validated by YALE is the first and only early detection test for pre-metabolic diseases.

• β-Cell Test uses a proprietary measure to identify and detect potential onset of type 1 and the development of pre-diabetes and type 2 diabetes. This test will revolutionize the identification and potential treatment options for the most expensive disease in the world.
• The β-Cell Test is designed to replace the current method of identifying diabetes, the A1c Test, and can be used to manage diabetes through identifying the severity of β-cell death.

Although the A1c Test is currently recognized as the gold standard test in Diabetes management, our data supports that the β-Cell Test identifies Diabetes in subjects earlier than the A1c Test.

• Early detection of Diabetes provides various benefits including, but not limited to, the potential for earlier diabetes management treatments and lessened severity of the disease as a result
• The β-Cell Test also provides monitoring of Diabetes progression and other disorders associated with β-cell death